Skip to main content
. 2021 Sep 27;7(3):00383-2021. doi: 10.1183/23120541.00383-2021

TABLE 1.

Characteristics of the study population

All subjects No incident COPD events # Incident COPD events # p-value for no COPD – COPD difference
Subjects n 615 561 54
Person-years of observation 13 553 12 717 836
Age at baseline (years) 625 56.8±4.8 571 56.8±4.7 54 56.4±4.9 0.53
BMI (kg·m−2) 625 25.6±3.3 571 25.6±3.2 54 25.2±3.5 0.34
FEV1 (% pred) 615 88.7±16.4 561 90.2±15.0 54 72.2±20.9 <0.0001
FEV1/VC (% pred) 615 99.6±11.4 561 100.0±9.8 54 87.0±17.8 <0.0001
N2-slope (% N2/L) + 604 2.0±1.5 552 1.9±1.4 52 3.1±2.1 <0.0001
N2-slope (% pred) + 604 162±118 552 154±110 52 253±155 <0.0001
Smoking habits 625 <0.0001
 Never-smoker (%) 125 20.0 121 21.2 4 7.4
 Ex-smoker (%) 194 31.0 181 31.4 13 24.1
 Current smoker (%) 306 49.0 269 47.1 37 68.5
Non-productive cough (%) § 149 24.1 124 21.9 25 47.2 <0.0001
Productive cough (%) § 139 22.5 115 20.3 24 45.3 <0.0001
Wheezing (%) § 219 35.4 186 32.9 33 62.3 <0.0001
Dyspnoea (%) § 160 26.0 131 23.3 29 54.7 <0.0001
Total symptom score ƒ 619 2.0±2.6 556 1.8±2.4 53 4.4±3.2 <0.0001

Data are presented as n or mean±sd, unless otherwise stated. Continuous variable differences were tested using the Mann–Whitney U-test; discrete variables were tested using the Chi-squared test. BMI: body mass index; FEV1: forced expiratory volume in 1 s; VC: vital capacity; N2-slope: alveolar slope of the single-breath nitrogen test. #: first admission to hospital or death related to COPD; : according to Hedenström et al. [16]; +: according to Sixt et al. [17]; §: percentage of subjects reporting any of the symptoms in each symptom group; ƒ: mean of all the reported symptoms.